Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Digital agriculture
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    EPO TIR study-Agriculture-web-720 x 237

    Technology insight report on digital agriculture

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventors Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Technologies
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
Website
cancel
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Overview
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Digital agriculture
        • Go back
        • Overview
        • Plant agriculture
        • Artificial growth conditions
        • Livestock management
        • Supporting technologies
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
      • International treaties
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2025 activities
        • 2024 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • CodeFest
        • Go back
        • CodeFest 2026 on patent and IP portfolio (e)valuation
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • Core activities
          • Stories and insights
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Technologies
        • Go back
        • Overview
        • Innovation against cancer
        • Assistive robotics
        • Energy enabling technologies
          • Go back
          • Overview
          • Publications
        • Energy generation technologies
        • Water technologies
        • Plastics in transition
        • Space technologies
        • Digital agriculture
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
          • Go back
          • Overview
          • Publications
        • Research universities and public research organisations
        • Women inventors
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
        • Collaboration with European actors
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2024
          • Go back
          • Overview
          • Executive summary
          • Driver 1 – People
          • Driver 2 – Technologies
          • Driver 3 – High-quality, timely products and services
          • Driver 4 – Partnerships
          • Driver 5 – Financial Sustainability
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions and opinions
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 1998/21 (anti-TNFalpha antibody formulation / RICHTER GEDEON) 25-07-2023
Facebook X Linkedin Email

T 1998/21 (anti-TNFalpha antibody formulation / RICHTER GEDEON) 25-07-2023

European Case Law Identifier
ECLI:EP:BA:2023:T199821.20230725
Date of decision
25 July 2023
Case number
T 1998/21
Petition for review of
-
Application number
15808356.8
IPC class
C07K 16/24
A61K 39/395
A61K 47/10
A61K 47/18
A61K 47/00
A61K 39/00
A61K 9/00
A61K 47/26
Language of proceedings
EN
Distribution
NO DISTRIBUTION (D)

Download and more information:

Decision in EN 389.62 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
Unpublished
Application title

Pharmaceutical anti-TNF-alpha antibody formulation

Applicant name
Richter Gedeon Nyrt.
Opponent name
-
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 113
European Patent Convention Art 123(2)
Rules of procedure of the Boards of Appeal Art 13(2)
European Patent Convention Art 111(1)
European Patent Convention R 103(1)(a)
Keywords

Appealed decision sufficiently reasoned (no)

Amendment after summons - taken into account (yes)

Amendments - added subject-matter (no)

Reimbursement of appeal fee (no)

Catchword
-
Cited decisions
-
Citing decisions
-

I. The appeal of the patent proprietor ("the appellant") lies from the decision of the opposition division to revoke European patent 3 212 667 ("the patent").

II. The patent was granted on European patent application No. 15 808 356.8 which was filed as an international application PCT/EP2015/074986 (the "application as filed"), published as WO 2016/066688.

III. Oppositions were filed by opponents 1 and 2. During the opposition proceedings, opponent 3 filed a notice of intervention. The oppositions were filed against the patent as a whole on the grounds for opposition set out in Article 100(a), (b) and (c) EPC.

IV. In its decision, the opposition division only dealt with the ground for opposition under Article 100(c) EPC and inter alia held that the subject-matter of the claims of the patent as granted (main request) and of the auxiliary requests extended beyond the content of the application as filed. It further stated that auxiliary requests 1 to 4, 4a to 4h, 5 to 12, filed with the letter of 6 May 2021, were "deemed to be on time" (see point 24 of the decision).

V. With the statement of grounds of appeal, the appellant filed sets of claims of new auxiliary requests 4e(i) and 4e(ii) and provided arguments on why neither the claims of the patent as granted (main request) nor of any of auxiliary requests 1 to 4, 4a to f and 5 to 19 contained subject-matter extending beyond the content of the application as filed (Article 100(c) and Article 123(2) EPC, respectively). The appellant further requested reimbursement of the appeal fee pursuant to Rule 103(1)(a) EPC and submitted that its right to be heard under Article 113 EPC had been violated by the opposition division.

VI. Opponents 1 to 3 ("respondents I to III") replied to the statement of grounds of appeal with a joint letter and presented arguments regarding novelty and inventive step, sufficiency of disclosure of the claimed invention and added subject-matter. They also raised objections under Article 84 EPC regarding auxiliary requests 4 to 14 and 18 and under Article 123(3) EPC against auxiliary requests 4, 4c, 4d, 4f and 5 to 19.

VII. The appellant and the respondents submitted further letters.

VIII. The oral proceedings before the board, scheduled as requested by the parties, took place on 25 July 2023.

During the oral proceedings

- the appellant requested, as a further auxiliary request, that the patent be maintained in amended form based on the sets of claims of auxiliary requests 4g and 4h as filed during opposition proceedings and that they also be admitted into the appeal proceedings

- the respondents I, II and III withdrew their oppositions and subsequently left the oral proceedings, after which the oral proceedings were continued with the appellant as the sole party

- the appellant filed a new claim request and withdrew all other claim requests, i.e. the former main request and auxiliary requests 1 to 4, 4a to h, including 4e(i) and 4e(ii), and 5 to 19.

IX. At the end of the oral proceedings, the Chairman announced the board's decision.

X. The set of claims as submitted during oral proceedings reads:

"1. A liquid aqueous pharmaceutical formulation for use in the treatment of an autoimmune disorder, wherein said formulation is free of a phosphate buffer and comprises a therapeutically effective amount of Adalimumab in a buffered solution comprising L-histidine and citrate, said formulation having a pH of 5 to 5.5 and selected from the group consisting of:

(a) having a content of aggregated species of Adalimumab after storage at 5°C for 3 to 6 months of less than 5 %;

(b) having a content of aggregated species of Adalimumab after storage at 25°C for 3 to 6 months of less than 5 %;

(c) having a content of acidic species of Adalimumab after storage at 25°C for 3 to 6 months of less than 40 %;

(d) having a content of aggregated species of Adalimumab under heat stress conditions for 10 minutes at 55°C of less than 5 %;

(e) having a content of acidic species of Adalimumab under heat stress conditions for 10 minutes at 55°C of less than 40%; and

(f) retaining TNFalpha neutralizing activity of at least 80% after storage of 6 months at a temperature of 5°C or 25°C, and/or after being subjected to heat stress for 10 minutes at 55°C, freeze-thaw conditions at -20°C to 5°C and/or mechanical stress;

wherein the concentration of Adalimumab in the pharmaceutical formulation is 50 mg/mL and the formulation further comprises 5 to 20 mg/mL mannitol, 0.1 to 10 mg/mL polysorbate 80 and 5 to 7.5 mg/mL sodium chloride, and wherein the aggregated species are measured by Size Exclusion High Performance Liquid Chromatography (HP-SEC) and the acidic species are measured by Strong Cation Exchange (SCX) High Performance Liquid Chromatography (SCX-HPLC) and wherein the formulation is administered subcutaneously to the human subject in need thereof on a biweekly dosing regimen of every 13-15 days.

2. The formulation for use in accordance with claim 1, wherein the formulation is to be administered in combination with an additional therapeutic agent that inhibits TNFalpha production or activity, preferably methotrexate."

XI. The appellant's arguments, in so far as relevant to the decision, can be summarised as follows:

(a) Admittance of the new claim request filed during oral proceedings - Article 13(2) RPBA

The claim request addressed the board's objections raised at the oral proceedings. Its admittance was therefore justified.

(b) Amendments - Article 123(2) EPC - claims 1 and 2

Basis for the subject-matter of claims 1 and 2 could be found in claims 1, 3, 6, 10, 19, 25, 26, 27 and 29 of the application as filed in combination with page 25, lines 6 to 8 and last sentence of the first paragraph of the application as filed.

The features HP-SEC and SCX-HPLC found basis on page 4, paragraph 2 and page 11, paragraphs 3 and 4 and page 12, paragraph 2; page 13, paragraph 1; and page 29, last paragraph of the application as filed.

(c) Reimbursement of the appeal fee - Rule 103(1)(a) EPC - Violation of the right to be heard - Article 113 EPC

The appeal fee should be reimbursed pursuant to Rule 103(1)(a) EPC due to substantial procedural violations committed by the opposition division. The right to be heard had been violated by the opposition division because (i) the opposition division had not given the appellant an opportunity to present submissions on the allowability of the auxiliary requests at the oral proceedings and (ii) no reasoning was provided in the opposition division's decision regarding the alleged non-allowability of the auxiliary requests. Each of the above circumstances amounted to a substantial procedural violation.

In more detail: The decision under appeal confirmed that all auxiliary requests had been admitted into the proceedings (see point 24). Nonetheless, the decision to revoke the patent was based only on the main request (see point 20). In relation to the auxiliary requests it was merely stated that the opposition division only considered claims to be allowable under Article 123(2) EPC which contained all limitations of the formulations from Table 1 of the Examples and that none of the auxiliary requests "appear to comply" with the requirements of Article 123(2) EPC (see point 27 of the decision under appeal). The expression "appear to comply" conveyed the preliminary nature of the opposition division's view on the auxiliary requests and was a clear indication that the opposition division had not taken a decision on the auxiliary requests.

The appellant had, during the oral proceedings, asked the opposition division whether auxiliary requests IVe and IVf, which aimed to address the opposition division's objections explained in sections 26.2 and 26.4 of the decision under appeal, met the requirements of Article 123(2) EPC. In response, the chair had only asked whether these requests corresponded to one of the formulations in Table 1 of Example 1 (see point 11 of the minutes). After the appellant had denied this, the chair announced the decision to revoke the patent for failure of the main request to meet the requirements of Article 123(2) EPC (see point 15 of the minutes), without giving the appellant the chance to discuss the allowability of the auxiliary requests. Especially auxiliary requests IV, IVa to IVf, V, IX to XII which had been filed on 6 May 2021 had not been subject to discussion at all.

Moreover, the opposition division's decision provided no reasons for the alleged non-allowability of the auxiliary requests, which violated the appellant's right to be heard and constituted a procedural deficiency.

XII. The appellant's requests relevant to the decision were as follows:

- that the decision of the opposition division be set aside and that the patent be maintained in amended form based on the set of claims filed during the oral proceedings before the board

- that the board deals only with the issue of added subject-matter and that the case be remitted to the opposition division for further prosecution of the other issues under Article 100(a), (b) and (c) EPC and, furthermore

- that the appeal fee be reimbursed.

1. During the oral proceedings before the board, respondents I to III withdrew their oppositions. This means that they ceased to be party to the appeal proceedings as regards the substantive issues. The submissions of the former respondents may, nevertheless, be considered by the board in the appeal proceedings..

Admittance of claim request filed during oral proceedings before the board - Article 13(2) RPBA

2. Under Article 13(2) RPBA, any amendment to a party's appeal case made after notification of a summons to oral proceedings shall, in principle, not be taken into account unless there are exceptional circumstances, which have been justified with cogent reasons by the party concerned.

3. The board decided to admit the claim request filed during the oral proceedings before the board under Article 13(2) RPBA, because it was submitted to address objections under Article 84 EPC in relation to auxiliary request 4e(ii), raised ex officio by the board at the oral proceedings. The late filing of the auxiliary request was therefore justified by exceptional circumstances.

Amendments - Article 123(2) EPC

4. In the board's view, the subject-matter of claim 1 is not directly and unambiguously disclosed in the application as filed because at least two selections from different lists in the application as filed are needed to arrive at the claimed formulation, i.e. i) the selection of the L-histidine citrate buffer from the three buffers of claim 1 of the application as filed and ii) the selection of polysorbate as surfactant from page 25, paragraph 2 of the description. The claims of the application as filed mention "a surfactant" and "Polysorbate 80" but not "polysorbate". Moreover, NaCl is not present in the formulation of claim 1 as granted. However, no disclosure of a corresponding formulation lacking NaCl can be found in the application as filed.

5. In contrast, only one selection from a single list is needed to arrive at the formulation of present claim 1, i.e. the selection of the L-histidine citrate buffer from the list of three L-histidine buffers provided in claim 1 of the application as filed. The 50 mg/mL antibody concentration in the formulation (claim 3 of the application as filed) and the specific combination of excipients and their concentration ranges (claim 6 of the application as filed) are disclosed in dependent claims and do not require further selections from lists.

6. The limitation to the treatment of an autoimmune disorder (disclosed in claim 26 of the application as filed) does not affect the formulation and represents a restriction of the therapeutic goals. The feature of subcutaneous administration to a human subject in need thereof on a biweekly dosing regimen of every 13 to 15 days (claim 27 of the application as filed) is also directly disclosed via the dependencies of clam 27.

7. Claim 2 finds basis in claim 29 of the application as filed.

8. In view of the above considerations, the board concludes that the subject-matter of claims 1 and 2 does not extend beyond the content of the application as filed. Thus, claims 1 and 2 meet the requirements of Article 123(2) EPC.

Remittal - Article 111(1) EPC

9. The primary object of the appeal proceedings is to review the decision under appeal in a judicial manner (see Article 12(2) RPBA). In the case at hand, the decision under appeal was based solely on the issues of added subject-matter (Article 100(c) and Article 123(2) EPC, respectively), which have been addressed by the amended set of claims. No other ground for opposition initially raised in opposition was dealt with in the decision under appeal. Furthermore, independent claim 1 of this request (see point X. above) is directed to a formulation specifically defined by a combination of excipients contained therein and their concentration ranges, which were not present in any of the independent claims considered by the opposition division during the opposition proceedings, either in the decision under appeal or in one of its communications. Moreover, the appellant has requested that the case be remitted to the opposition division for further prosecution of the other issues under Article 100(a), (b) and (c) EPC. In these circumstances, the board considers that special reasons for remitting the case to the examining division within the meaning of Article 11, first sentence, RPBA, exist. Thus the board decided to remit the case to the opposition division for further prosecution (Article 111(1) EPC).

Reimbursement of the appeal fee - Rule 103(1)(a) EPC - substantial procedural violations - Article 113(1) EPC

10. A reimbursement of the appeal fee is ordered when an appeal is allowable, if such reimbursement is equitable by reason of a substantial procedural violation (Rule 103(1)(a) EPC).

11. The appellant submitted that its right to be heard had been violated in two ways, i) because it had not been given the opportunity to discuss the allowability of the auxiliary requests at the oral proceedings before the opposition division and ii) because in the decision under appeal, the opposition division did not give any reasons for the alleged non-allowability of the auxiliary requests. Both of these procedural defects amounted to substantial procedural violations.

Right to be heard during oral proceedings

12. The appellant did not request a correction of the minutes of the oral proceedings before the opposition division, thus, it must be assumed that the minutes properly reflect the course of events at oral proceedings.

13. According to point 11 of the minutes, the auxiliary requests were addressed at the oral proceedings: the appellant put questions in relation to specific auxiliary requests, the chair of the opposition division asked questions to the appellant, to which the appellant replied in the negative. Hence, at this stage of the oral proceedings, there had been opportunity for the appellant to make oral submissions on any of the auxiliary requests.

14. Moreover, according to the minutes, the appellant did not request the discussion of any of the auxiliary requests. Instead, it stated that no new claim request would be filed (see points 11 and 13 of the minutes). At the latest when the chair of the opposition division asked whether the hearing had been satisfactory from a technical point of view (see point 14 of the minutes), i.e. at a point at which it must have been apparent to the appellant that the discussion on substance was over, the appellant could have requested a discussion of the auxiliary requests.

15. In summary, the board cannot establish that the appellant did not have an opportunity to present its arguments on the auxiliary requests at the oral proceedings before the opposition division and that the appellant's right to be heard was violated during the oral proceedings.

Written reasoned decision

16. Pursuant to Rule 111(2) EPC decisions of the European Patent Office which are open to appeal must be reasoned. Adequate reasoning requires that there is a logical chain of arguments from which it can be derived why a request has been rejected. Moreover, due respect of the right to be heard under Article 113(1) EPC requires not only that the party concerned be given an opportunity to present comments, but also that those comments be taken into consideration by the deciding body.

17. It had been submitted by the respondents, but was contested by the appellant, that all auxiliary requests filed in the course of the written proceedings in opposition had been withdrawn by the appellant at the oral proceedings before the opposition division. However, this is not derivable from the minutes of the oral proceedings before the opposition division. According to point 11 of the minutes, the appellant stated that "no new [claim] request would be filed" and there is no indication that any of the previously filed auxiliary requests was withdrawn. It is to be expected that such a withdrawal of one or more requests, i.e. a relevant statement within the meaning of Rule 124(1) EPC, would have been expressly recorded in the minutes.

18. Had the appellant made an unclear statement in relation to one or more auxiliary requests, it would have been for the opposition division to clarify it and in so doing clarify the procedural status of the auxiliary requests, or alternatively for the respondents, for whom withdrawal of the claim requests would have been beneficial, to request clarification.

19. As the auxiliary requests filed in written proceedings in opposition had not been withdrawn by the appellant they should have been and considered and decided upon by the opposition division in its decision.

20. In relation to the auxiliary requests, it is stated in point 24 of the reasons of the decision under appeal that they "are deemed to be on time" without however indicating whether or not this means that they were admitted into the proceedings or not.

21. In point 27 of the decision it is stated that the opposition division "only saw compliance with Art. 123(2) EPC for the buffer compositions actually tested, as found in Table 1". The subsequent wording used by the opposition division "[a]ccordingly, none of the auxiliary requests on file appear to comply with the requirements of Art. 123(2) EPC" is of the character of a preliminary opinion rather than a decision, because of the use of the word "appear". Also, these two sentences are mere statements and no further explanation was given.

22. Finally, as explicitly stated in point 20 of the facts and submissions of the decision under appeal, the "decision is based on the Main Request (MR) being the claims as granted", implying that it is actually not based on the auxiliary requests. This is also confirmed by the opposition division's order referring solely to a revocation of the patent under Article 101(2) EPC (see point III of the decision under appeal and EPO Form 2331).

23. Thus, the decision under appeal did not contain a written reasoned decision on the auxiliary requests, which must therefore be regarded as insufficiently reasoned, contrary to the requirements of Rule 111(2) EPC. It must also be concluded that the appellant's right to be heard under Article 113(1) EPC has been infringed.

Reimbursement of the appeal fee

24. As set out above, the decision under appeal lacks any reasoning on the auxiliary requests. As these auxiliary requests were the appellant's fallback positions in relation to a revocation of the patent, the lack of reasoning and the associated violation of the right to be heard amount to a substantial procedural violation within the meaning of Rule 103(1)(a) EPC.

25. According to Rule 103(1)(a) EPC, the appeal fee shall be reimbursed in full, where the Board of Appeal deems an appeal to be allowable, if such reimbursement is equitable by reason of a substantial procedural violation. However, in the present case, the board does not consider the reimbursement of the appeal fee equitable.

26. No causal link between the substantial procedural violation and the decision that necessitated the filing of an appeal exists because the procedural violation did not affect the opposition division's decision on the main request (patent as granted) and in the appeal the appellant also challenged the opposition division's decision on this request. Thus, the appellant would have had to file an appeal to have the opposition division's decision on the main request reviewed.

27. Reimbursement is also not considered equitable because none of the auxiliary requests filed before the opposition division and maintained by the appellant in the appeal was held allowable by the board, prior to the withdrawal of those requests by the appellant at the oral proceedings before the board.

28. The fact that the appeal is allowable, i.e. that the decision under appeal is set aside and the case is remitted for further prosecution, is the consequence of the board's decision to admit the claim request filed at the oral proceedings before it and to hold that claim request as compliant with Article 123(2) EPC. That claim request was admitted as a reaction to objections raised by the board ex officio against a claim request that had been presented on appeal for the first time and was admitted by the board.

29. In these circumstances, the board does not consider the reimbursement of the appeal fee to be equitable. Thus, the request for reimbursement of the appeal fee under Rule 103(1)(a) EPC is rejected.

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division for further prosecution.

3. The request for reimbursement of the appeal fee is rejected.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility

We use cookies

We use cookies on our website to support technical features that enhance your user experience. We also use analytics. 

To watch videos on our website, you must accept YouTube cookies. For more information, check YouTube’s privacy policy.